Geneart AG

Geneart AG (ETR:G6A) is a Germany-based company engaged in the provision of integrated system solutions for deoxyribonucleic acid (DNA) engineering and processing in order to deliver improved drugs and biotech products. It is divided into three business areas: Red Biotechnology, active in the filed of protein drugs, deoxyribonucleic acid (DNA)-based drugs and recombinant vaccines; White Biotechnology, includes biocatalysts, and Green Biotechnology, engaged in production of biopharmaceuticals in plants and transgenic plants. Geneart's core business is gene synthesis and the production of artificial genes. Its spectrum of services includes gene optimization and synthesis, gene evolution services, and the development and manufacture of deoxyribonucleic acid (DNA)-based agents, including plasmid DNA. The Company is able to customize genes for specific customer applications with the GeneOptimizer Software used to model the properties of pharmaceutical and biotechnological products.